Kopp Investment Advisors Llc increased its stake in Horizon Pharma Plc (HZNP) by 403.79% based on its latest 2017Q3 regulatory filing with the SEC. Kopp Investment Advisors Llc bought 89,380 shares as the company’s stock declined 38.11% while stock markets rallied. The institutional investor held 111,515 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.41M, up from 22,135 at the end of the previous reported quarter. Kopp Investment Advisors Llc who had been investing in Horizon Pharma Plc for a number of months, seems to be bullish on the $2.28 billion market cap company. The stock decreased 1.42% or $0.2 during the last trading session, reaching $13.89. About 1.17M shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since February 17, 2017 and is downtrending. It has underperformed by 44.83% the S&P500.

Girard Partners Ltd decreased its stake in Procter And Gamble Co (PG) by 8.76% based on its latest 2017Q3 regulatory filing with the SEC. Girard Partners Ltd sold 3,736 shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 38,929 shares of the package goods and cosmetics company at the end of 2017Q3, valued at $3.54 million, down from 42,665 at the end of the previous reported quarter. Girard Partners Ltd who had been investing in Procter And Gamble Co for a number of months, seems to be less bullish one the $208.24 billion market cap company. The stock increased 0.23% or $0.19 during the last trading session, reaching $82.6. About 10.37M shares traded or 22.36% up from the average. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since February 17, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Girard Partners Ltd, which manages about $604.19 million and $484.32M US Long portfolio, upped its stake in Philip Morris Intl Inc (NYSE:PM) by 2,929 shares to 37,926 shares, valued at $4.21M in 2017Q3, according to the filing. It also increased its holding in Vanguard Tax Managed Intl Fd Ftse Dev Mkt (VEA) by 11,431 shares in the quarter, for a total of 35,233 shares, and has risen its stake in Vanguard Index Fds Value (VTV).

Since August 15, 2017, it had 0 buys, and 3 selling transactions for $3.16 million activity. Taylor David S had sold 6,382 shares worth $587,402. $422,374 worth of stock was sold by Giovanni Ciserani on Tuesday, August 15. 1,572 shares valued at $144,688 were sold by Fish Kathleen B on Tuesday, August 15. The insider Bishop Steven D sold $318,644. On Tuesday, August 15 the insider Abdelfattah Mohamed Samir Abdelrazek sold $77,130. FergusonMchugh MaryLynn also sold $265,554 worth of The Procter & Gamble Company (NYSE:PG) on Tuesday, August 15.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 77 analyst reports since August 4, 2015 according to SRatingsIntel. CLSA upgraded The Procter & Gamble Company (NYSE:PG) rating on Wednesday, October 26. CLSA has “Outperform” rating and $95 target. On Tuesday, July 21 the stock rating was initiated by Sterne Agee CRT with “Neutral”. Stifel Nicolaus maintained The Procter & Gamble Company (NYSE:PG) on Monday, September 18 with “Hold” rating. As per Tuesday, August 1, the company rating was maintained by RBC Capital Markets. Morgan Stanley upgraded the stock to “Overweight” rating in Tuesday, January 26 report. The firm has “Buy” rating given on Wednesday, October 26 by B. Riley & Co. The rating was upgraded by Suntrust Robinson on Tuesday, September 8 to “Buy”. Stifel Nicolaus upgraded it to “Buy” rating and $85.0 target in Tuesday, January 19 report. As per Tuesday, September 8, the company rating was upgraded by SunTrust. Zacks downgraded the stock to “Hold” rating in Tuesday, August 4 report.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 55 analyst reports since September 9, 2015 according to SRatingsIntel. The rating was downgraded by Mizuho to “Neutral” on Friday, December 9. Mizuho maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Tuesday, September 13 with “Buy” rating. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) earned “Buy” rating by JMP Securities on Wednesday, September 27. The firm earned “Equal-Weight” rating on Monday, July 11 by Morgan Stanley. The stock has “Buy” rating by BMO Capital Markets on Tuesday, September 26. The firm has “Buy” rating given on Tuesday, May 3 by Mizuho. The stock of Horizon Pharma Public Limited Company (NASDAQ:HZNP) has “Market Perform” rating given on Friday, September 16 by Cowen & Co. Stifel Nicolaus maintained the shares of HZNP in report on Tuesday, June 27 with “Buy” rating. The rating was maintained by Mizuho on Monday, August 7 with “Hold”. The firm has “Neutral” rating by Citigroup given on Tuesday, August 9.